Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
233
-
Total 13F shares, excl. options
-
98,807,721
-
Shares change
-
-134,974
-
Total reported value, excl. options
-
$4,765,076,153
-
Value change
-
-$16,595,617
-
Put/Call ratio
-
118%
-
Number of buys
-
122
-
Number of sells
-
-121
-
Price
-
$48.20
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2021
301 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q1 2021.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98,807,721 shares
of 158,835,667 outstanding shares and own 62.2% of the company stock.
Largest 10 shareholders include FMR LLC (17,970,625 shares), VANGUARD GROUP INC (11,124,376 shares), BlackRock Inc. (9,299,599 shares), LORD, ABBETT & CO. LLC (4,695,301 shares), RA CAPITAL MANAGEMENT, L.P. (4,636,146 shares), WELLINGTON MANAGEMENT GROUP LLP (4,316,761 shares), ALKEON CAPITAL MANAGEMENT LLC (4,090,691 shares), STATE STREET CORP (3,259,281 shares), Capital World Investors (3,153,943 shares), and MAVERICK CAPITAL LTD (2,971,136 shares).
This table shows the top 233 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.